The European Blood and Blood Forming Organs Medicine sales in 2023 showed varied trends across different nations. Belgium led the sales in 2024 with a significant value of 961.5 million euros, displaying a robust growth of 9.47% from the previous year. Austria and Luxembourg also recorded positive trends in sales with growth rates of 6.16% and 6.91% respectively. Conversely, Greece witnessed a contraction in sales by 3.83%, and Slovakia saw a substantial decline of 8.2%. Latvia and Slovenia experienced a healthy increase in sales, marked by 8.72% and 9.04% respectively.
Future trends to watch for European Blood and Blood Forming Organs Medicine include:
- Continued market growth driven by advancements in medical research and treatment innovations.
- Potential market fluctuations influenced by healthcare policy changes and regulatory dynamics.
- Increased investments in personalized medicines and technology integration across the healthcare sector.
Top countries in Blood and Blood Forming Organs Medicine Sales by Country
| # | 7 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Belgium | 961.5 | 2023 | +7.9% | +9.47% | View data |
| 2 | 2 Greece | 897.2 | 2023 | +10.66% | -3.83% | View data |
| 3 | 3 Austria | 451.7 | 2023 | +5.22% | +6.16% | View data |
| 4 | 4 Slovakia | 139.4 | 2023 | -10.81% | -8.2% | View data |
| 5 | 5 Slovenia | 84 | 2023 | +6.06% | +9.04% | View data |
| 6 | 6 Latvia | 48 | 2023 | +4.58% | +8.72% | View data |
| 7 | 7 Luxembourg | 23.6 | 2023 | +4.42% | +6.91% | View data |
